How have reimbursement policies
changed Poland’s pharma and healthcare markets?
Market report details results,
explores forecasts for development to 2015.
Implementation of the provisions of
Poland’s Reimbursement Act has created visible consequences in the country’s
pharmaceutical and healthcare markets. The experienced analysts at PMR have
kept close watch on these changes, observing events and collecting data that
documents variations in sales values of various medications, the value of the
hospital market and best-selling medicines across the industry.
The result of this study is the
publication of Pharmaceutical and healthcare market in Poland 2013, Development
forecasts for 2013-2015. This report analyses overall market conditions
and evaluates the changes attributed to the Reimbursement Act as observed in
pharmacy and hospital environments. It profiles the leading pharmaceutical
manufacturers and examines products in terms of their ATC designations,
revealing the opportunities and obstacles to success in these markets and
predictions for changes in the future.
To Read the Complete Report with TOC
Visit: http://www.marketresearchreports.biz/analysis-details/pharmaceutical-and-healthcare-market-in-poland-2013
The report presents foundational
data on the value of the pharmacy and healthcare markets, emphasizing the
changes that have come to light since the Reimbursement Act was first
implemented. It covers modifications to the list made in 2012 and 2013, and
analyses each of the applicable ATC categories in terms of the effects of
reimbursement policies on profitability. It contains listings of the top
selling pharmaceutical preparations as well as dietary supplements and newly
introduced generic and innovative products.
Information about consumer
preferences with regard to innovative treatments, demographic details in
relation to use of medicines and ample epidemiological data combine to give
readers a complete overview of market activity. Profiles of leading
pharmaceutical and healthcare companies reveal revenues and strategies for
adaptation to changing conditions that are forecast to continue during the
period 2013-2015.
Reimbursement information is provided as follows: NFZ expenditures for open reimbursements, chemotherapy programmes and other drugs during 2012, NFZ total 2012 expenditures for drugs according to ATC category, level of required copayment and by voivodship. Expected changes to drug and reimbursement lists over the forecast period are also furnished.
This document also describes the
situation in Poland’s healthcare segment, supplying data on the total numbers
of doctors and their applicable specialties and hospitals in terms of quantity,
patient capacity, and NFZ contract status. It instructs readers on the
characteristics that distinguish medical spending as part of the public or
private healthcare sector in Poland.
Pharmaceutical and healthcare market
in Poland 2013, Development forecasts for 2013-2015 is an indispensible
information source for pharmaceutical manufacturers, healthcare services
providers and the companies that furnish their supplies, and providers of consultancy,
financial and research and analysis services.
Users will find this report
especially valuable in their efforts to begin and expand business operations,
assess potential investment opportunities, prepare forecasts for sales and
earnings, and examine the value and business activities of competing business
interests. Government and commerce organisations will also utilise the data and
forecasts to prepare internal and external reporting on Poland’s pharmaceutical
and healthcare sector.
About Us
MarketResearchReports.Biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz
services are especially designed to save time and money of our clients. We are
a one stop solution for all your research needs, our main offerings are
syndicated research reports, custom research, subscription access and
consulting services. We serve all sizes and types of companies spanning across
various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment